Active Ingredient(s): Teprotumumab-trbw
FDA Approved: * January 21, 2020
Category: Vision / Eye Health

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Tepezza Overview

Teprotumumab, sold under the brand name Tepezza, is a medication used to treat adults with thyroid eye disease, a rare condition where the muscles and fatty tissues behind the eye become inflamed, causing the eyes to bulge outwards.[1] The most common side effects are muscle spasm, nausea, hair loss, diarrhea, fatigue, high blood sugar, hearing loss, dry skin, altered sense of taste and headache.[1] Teprotumumab should not be used if pregnant, and women of chil...

Read more Tepezza Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Teprotumumab

Recent Tepezza Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

  • Injection: 500mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Tepezza: (1 result)

Sorted by National Drug Code
  • 75987-130 Tepezza 500 mg Intravenous Injection, Powder, Lyophilized, for Solution by Horizon Therapeutics USA, Inc.

Other drugs which contain Teprotumumab-trbw or a similar ingredient: (1 result)